W. A. Sheremata

732 total citations
8 papers, 592 citations indexed

About

W. A. Sheremata is a scholar working on Pathology and Forensic Medicine, Neurology and Epidemiology. According to data from OpenAlex, W. A. Sheremata has authored 8 papers receiving a total of 592 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Pathology and Forensic Medicine, 2 papers in Neurology and 2 papers in Epidemiology. Recurrent topics in W. A. Sheremata's work include Multiple Sclerosis Research Studies (2 papers), Cell Adhesion Molecules Research (2 papers) and HIV Research and Treatment (1 paper). W. A. Sheremata is often cited by papers focused on Multiple Sclerosis Research Studies (2 papers), Cell Adhesion Molecules Research (2 papers) and HIV Research and Treatment (1 paper). W. A. Sheremata collaborates with scholars based in United States and Canada. W. A. Sheremata's co-authors include Alireza Minagar, Lucía Mercedes Mauro, Wenche Jy, Joaquín J. Jiménez, Yeon S. Ahn, Lawrence L. Horstman, Patricia W. Nance, Gerd G. Maul, G T Hensley and M. Judith Donovan Post and has published in prestigious journals such as Neurology, The Journal of Urology and American Journal of Roentgenology.

In The Last Decade

W. A. Sheremata

8 papers receiving 560 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
W. A. Sheremata United States	7	186	134	130	125	65	8	592
Karen O’Connell Ireland	13	104 0.6×	231 1.7×	106 0.8×	136 1.1×	18 0.3×	29	683
C Laterre Belgium	13	256 1.4×	52 0.4×	278 2.1×	54 0.4×	32 0.5×	27	740
Adam Starkey United States	11	274 1.5×	48 0.4×	97 0.7×	71 0.6×	23 0.4×	27	783
Juha-Pekka Erälinna Finland	14	78 0.4×	406 3.0×	161 1.2×	196 1.6×	19 0.3×	24	748
Sibel P. Yentür Türkiye	16	116 0.6×	85 0.6×	224 1.7×	217 1.7×	25 0.4×	31	863
Lucienne Papadaki United Kingdom	19	124 0.7×	100 0.7×	96 0.7×	269 2.2×	6 0.1×	35	954
M Arthuis France	13	152 0.8×	64 0.5×	67 0.5×	57 0.5×	9 0.1×	57	556
Christian Fredrik Lindboe Norway	15	84 0.5×	112 0.8×	219 1.7×	16 0.1×	53 0.8×	32	652
P. R. Egbert United States	15	122 0.7×	45 0.3×	52 0.4×	220 1.8×	38 0.6×	19	1.0k
Edward Cupler Saudi Arabia	16	347 1.9×	108 0.8×	439 3.4×	141 1.1×	14 0.2×	53	1.3k

Countries citing papers authored by W. A. Sheremata

Since Specialization

Citations

This map shows the geographic impact of W. A. Sheremata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. A. Sheremata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. A. Sheremata more than expected).

Fields of papers citing papers by W. A. Sheremata

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. A. Sheremata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. A. Sheremata. The network helps show where W. A. Sheremata may publish in the future.

Co-authorship network of co-authors of W. A. Sheremata

This figure shows the co-authorship network connecting the top 25 collaborators of W. A. Sheremata. A scholar is included among the top collaborators of W. A. Sheremata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. A. Sheremata. W. A. Sheremata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Minagar, Alireza, Wenche Jy, Joaquín J. Jiménez, et al.. (2001). Elevated plasma endothelial microparticles in multiple sclerosis. Neurology. 56(10). 1319–1324. 248 indexed citations

2.

Minagar, Alireza, et al.. (2000). Reduction of Relapses in Multiple Sclerosis after Anti-Alpha4 Integrin Antibody (Natalizumab). International Journal of MS Care. 2(1). 2–5. 6 indexed citations

3.

Nance, Patricia W., W. A. Sheremata, Sharon Lynch, et al.. (1997). Relationship of the Antispasticity Effect of Tizanidine to Plasma Concentration in Patients With Multiple Sclerosis. Archives of Neurology. 54(6). 731–736. 61 indexed citations

4.

Nance, Patricia W., et al.. (1994). Efficacy and safety of tizanidine in the treatment of spasticity in patients with spinal cord injury. North American Tizanidine Study Group.. PubMed. 44(11 Suppl 9). S44–51; discussion S51. 66 indexed citations

5.

Sheremata, W. A., et al.. (1993). High‐dose zidovudine induction in HTLV‐I‐associated myelopathy. Neurology. 43(10). 2125–2125. 46 indexed citations

6.

Post, M. Judith Donovan, et al.. (1988). CT, MR, and pathology in HIV encephalitis and meningitis. American Journal of Roentgenology. 151(2). 373–380. 98 indexed citations

7.

Tobias, Jeffrey, et al.. (1985). MR imaging of multiple sclerosis: comparison with clinical and CT examinations in 74 patients. American Journal of Roentgenology. 145(5). 957–964. 54 indexed citations

8.

Lockhart, Jorge L., et al.. (1981). Neurogenic Bladder Dysfunction in the Shy-Drager Syndrome. The Journal of Urology. 126(1). 119–121. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact